Navigation Links
Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
Date:6/26/2008

BOSTON, June 26 /PRNewswire-USNewswire/ -- Headache specialists meet today in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.

For additional information, contact: Gina Czark at 312.558.1770, ext. 139 or gczark@pcipr.com or visit http://www.headachenews.org.

Among the topics being presented, include:

-- WHY PAIN BECOMES CHRONIC: Research shows previously unknown role certain

brain cells play in triggering chronic headaches for 9 million Americans

Think that pain medication is helping you ease the throbbing of a

headache? Think again. Researchers discovered neurons are not the only

carrier of pain signals to the brain. Glial cells, which outnumber

neurons 20:1, have been shown to prompt chronic pain in a variety of

ways, such as by a virus, nerve damage or even medication. Morphine and

other opiates also activate glial cells, which mean those drugs

you're taking to alleviate pain might actually be making it worse.

-- FIRST RIGOROUS TEST OF MAGNETIC STIMULATION DEVICE SHOWS PROMISE FOR

SHORT-CIRCUITING MIGRAINES: Research shows 7 million Americans could

benefit from this treatment

Imagine simply zapping away the pain at the onset of a migraine, instead

of gulping medication and waiting for relief. Researchers are presenting

encouraging results showing a portable transcranial magnetic stimulation

device would help an estimated 39 percent of migraine sufferers. The

device, about the size and weight of a hairdryer, works by placing it to

the back of the
'/>"/>

SOURCE American Headache Society
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
2. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
3. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
4. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
7. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
8. Leading Immunologists Convene in Boston
9. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
10. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
11. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS )ann...nerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinue...gphase2btrialofRG7128,afirst-in-classnucleosideana...titisCvirus(HCV)infection.Thedecisionwasreachedaft...mittee(DMC)ofallavailablesafetydatafromthefirstcoh...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--CeptionTherapeutics,Inc...on,Inc.(Nasdaq: CEPH )todayannouncedresultsfromaPh...satreatmentforpediatriceosinophilicesophagitis(EoE...primaryendpointsofchangesinesophagealeosinophillev...hatpatientstreatedwithCINQUILshowedastatisticallys...
(Date:11/20/2009)...wswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq...l first quarter ended September 30, 2009. ,, ...nue decreased approximately $234,000, or 2.7%, to ...tember 30, 2009 as compared to the same period las... net revenue of $8,434,000 compared with $8,669,00...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 1Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 2Carnegie Mellon team makes sequestration recommendations 9339 1Carnegie Mellon team makes sequestration recommendations 9339 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
...da and Scripps Research in La ...and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCal... ), a,biopharmaceutical company focused on oncolog...t biomedical research organization, today announce...asses of protein kinase,inhibitors for the treatme...
...ncorporated (Nasdaq: KOSN ) today announced that ...e company,s lead Hsp90 inhibitor, from a Phase,2 t...with HER2-positive,metastatic breast cancer, at th...linical Oncology (ASCO), being held at McCormick P...bstract 1027, titled, "Phase 2 trial of the Hsp90 ...
Other Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 3
(Date:11/23/2009)...,, SANDIEGO,Nov.23/PRNewswire/--VictoryPharma,I...74;DoseCard,afurtherextensionofVictory,sNAPRELANfr...tswhorequirerelieffrommildtomoderatepainandinflamm...initisandbursitis.Itisalsodesignedforpatientssuffe...ereceivingothertherapiesandneedadditionalanti-infl...
(Date:11/23/2009)...pert says findings support link between mental and...althDay News) -- Being depressed might take as man... suggests. , However, a combination of depressi...than just depression. , Researchers came to the... survey of more than 60,000 people. During the fou...
(Date:11/23/2009)...most 20 percent get infected within one year of st...MONDAY, Nov. 23 (HealthDay News) -- As many as one...ansmitted disease (STD), many infected soon after ...ort shows. , "The high burden of STDs among tee...d study author Dr. Sami L. Gottlieb, from the divi...
(Date:11/23/2009)...Women who store fat on their waist in middle age a...hen they get older, reveals a new study from the S...blished in the scientific journal Neurology . , ...s at greater risk of dying prematurely due to a he...ior lecturer at the Sahlgrenska Academy. "If they ...
(Date:11/23/2009)...MAYWOOD, Il. -- A Loyola University Health System ...ics is morbidly obese -- approximately 100 pounds ...62.4 percent of U.S. adults with Type 2 diabetes a...ng African American adults with Type 2 diabetes, 1...besity among people with diabetes is increasing at...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Depression May Up Death Risk to That of Smoking 2Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Diabetics show alarming increase in morbid obesity 2
... A Lifeclinic LC300 automated blood pressure ...me talk show, The Doctors. The series airs each we...m a panel of four practicing medical professionals... on the new CBS daytime talk show, The Doctors. Th...
...ded and gsi interactive Named as Digital Marketing...TSBURGH, Pa., Dec. 16 GSI Commerce Inc. (Nasdaq: ...tichannel solutions, today announced a multiyear e...lements. Under the agreement, which runs through ...
... reach immune cells in just 4 hours , , TU...male-to-female transmission of HIV -- in which the...reach immune cells in just four hours -- has been ...tercourse, because the large HIV virus couldn,t pe...
...., Dec. 16 Third Brigade,( http://www.thirdbrigad...ion,for dynamic datacenters, today announced that ...eployed Third Brigade Deep Security for increased,...l,data resulting from nearly three quarters of a m...
...ty letter scores increased similarly in all treatm...swire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX:...terim analysis for the Phase II RADICAL study (Red... study comparing reduced-fluence Visudyne(R)-Lucen...
... CeloNova BioSciences, Inc., announced,today that ...e U.S. Food and,Drug Administration (FDA) for Embo...icated for the treatment of hypervascularized tumo...l sales of,Embozene(TM) Microspheres will begin im...
Other Medicine News:Health News:Benefits of a Lifeclinic LC300 Automated Blood Pressure Monitor Recently Featured on Daytime Medical Talk Show 2Health News:GSI Commerce and GNC Corporation Extend E-Commerce Agreement Through 2017 2Health News:GSI Commerce and GNC Corporation Extend E-Commerce Agreement Through 2017 3Health News:HIV Can Penetrate a Woman's Healthy Genital Skin 2Health News:Beth Israel Deaconess Medical Center Maintains Healthy IT Servers With Third Brigade 2Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 2Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 3Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 4Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 5Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 2Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 4
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: